OCULAR THERAPEUTIX, INC (OCUL): Other Sanjay Nayak took another position

OCUL · Nasdaq · Pharmaceutical Preparations · Large accelerated filer · MA · Form 8-K filed 2026-10-16

Sanjay Nayak, Chief Strategy Officer, resigned effective October 16, 2026, to become CEO of a private company.

Open seatNo successor namedEffective within 30 days

Events in this filing

1 event: Departure (Other).

Names, stated reasons, successor status, compensation terms and the evidence quotes are shown to subscribers. See plans

Item 5.02 as filed

Item 5.02 Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 14, 2026, Sanjay Nayak, M.B.B.S., Ph.D.,
Chief Strategy Officer of Ocular Therapeutix, Inc. (the “Company”), notified the Company of his resignation from the Company,
effective October 16, 2026, to become the Chief Executive Officer of a privately-held company.

Source filing on EDGAR →